Drug
Two Injections Lenti Hpv 07
Two Injections Lenti Hpv 07: highest development phase Phase 1/2, developed by Theravectys S.A.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Theravectys S.A.
Trials
| Drug | Phase | Indication |
|---|---|---|
| Two IM injections Lenti-HPV-07 NCT06319963 | Phase 1/2 | HPV-Related Cervical Carcinoma |
Latest
No recent events.
Follow Two Injections Lenti Hpv 07 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.